Appendix References

Rashmi B. Halker Singh; Juliana H. VanderPluym; Allison S. Morrow; Meritxell Urtecho; Tarek Nayfeh; Victor D. Torres Roldan; Magdoleen H. Farah; Bashar Hasan; Samer Saadi; Sahrish Shah; Rami Abd-Rabu; Lubna Daraz; Larry J. Prokop; Mohammad Hassan Murad; Zhen Wang

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Singh RBH, VanderPluym JH, Morrow AS, et al. Acute Treatments for Episodic Migraine [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Dec. (Comparative Effectiveness Review, No. 239.)

Cover of Acute Treatments for Episodic Migraine

Acute Treatments for Episodic Migraine [Internet].

Show details

Contents

< PrevNext >

Appendix MAppendix References

1.: Aggarwal D, Heim AJ, Bittel B, et al. A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine. Kans J Med. 2020;13(Suppl 2):2–5. PMID: 32256967. [PMC free article: PMC7106987] [PubMed: 32256967]
2.: Alemdar M, Pekdemir M, Selekler HM. Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial. Clin Ther. 2007 Jul;29(7):1441–7. PMID: 17825695. [PubMed: 17825695]
3.: Amiri H, Ghodrati N, Nikuyeh M, et al. Comparison of granisetron and metoclopramide in the treatment of pain and emesis in migraine patients: A randomized controlled trial study. Turk J Emerg Med. 2017 Jun;17(2):61–4. PMID: 28616617. [PMC free article: PMC5459513] [PubMed: 28616617]
4.: Aurora SK, Silberstein SD, Kori SH, et al. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine. Headache. 2011 Apr;51(4):507–17. PMID: 21457235. [PubMed: 21457235]
5.: Aurora SK, Rozen TD, Kori SH, et al. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine. Headache. 2009 Jun;49(6):826–37. PMID: 19545249. [PubMed: 19545249]
6.: Avcu N, Dogan NO, Pekdemir M, et al. Intranasal Lidocaine in Acute Treatment of Migraine: A Randomized Controlled Trial. Ann Emerg Med. 2017 Jun;69(6):743–51. PMID: 27889366. [PubMed: 27889366]
7.: Banerjee M, Findley L. Propranolol in the treatment of acute migraine attacks. Cephalalgia. 1991 Sep;11(4):193–6. PMID: 1742775. [PubMed: 1742775]
8.: Baratloo A, Mirbaha S, Delavar Kasmaei H, et al. Intravenous caffeine citrate vs. magnesium sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study. Korean J Pain. 2017 Jul;30(3):176–82. PMID: 28757917. [PMC free article: PMC5532524] [PubMed: 28757917]
9.: Bell R, Montoya D, Shuaib A, et al. A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med. 1990 Oct;19(10):1079–82. PMID: 2221511. [PubMed: 2221511]
10.: Bigal ME, Bordini CA, Tepper SJ, et al. Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study. Headache. 2002 Oct;42(9):862–71. PMID: 12390611. [PubMed: 12390611]
11.: Bigal ME, Bordini CA, Speciali JG. Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial. J Emerg Med. 2002 Aug;23(2):141–8. PMID: 12359281. [PubMed: 12359281]
12.: Bigal ME, Bordini CA, Tepper SJ, et al. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia. 2002 Jun;22(5):345–53. PMID: 12110110. [PubMed: 12110110]
13.: Bigal ME, Bordini CA, Speciali JG. Intravenous metamizol (Dipyrone) in acute migraine treatment and in episodic tension-type headache-a placebo-controlled study. Cephalalgia. 2001 Mar;21(2):90–5. PMID: 11422089. [PubMed: 11422089]
14.: Blanda M, Rench T, Gerson LW, et al. Intranasal lidocaine for the treatment of migraine headache: a randomized, controlled trial. Acad Emerg Med. 2001 Apr;8(4):337–42. PMID: 11282668. [PubMed: 11282668]
15.: Borhani Haghighi A, Motazedian S, Rezaii R, et al. Cutaneous application of menthol 10% solution as an abortive treatment of migraine without aura: a randomised, double-blind, placebo-controlled, crossed-over study. Int J Clin Pract. 2010 Mar;64(4):451–6. PMID: 20456191. [PubMed: 20456191]
16.: Boureau F, Joubert JM, Lasserre V, et al. Double-blind comparison of an acetaminophen 400 mg-codeine 25 mg combination versus aspirin 1000 mg and placebo in acute migraine attack. Cephalalgia. 1994 Apr;14(2):156–61. PMID: 8062355. [PubMed: 8062355]
17.: Brandes JL, Klise S, Krege JH, et al. Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study). Cephalalgia. 2019 Aug 21:333102419864132. PMID: 31433669. [PMC free article: PMC6779019] [PubMed: 31433669]
18.: Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache. 1986;26(4):168–71. PMID: 17199220. [PubMed: 3519528]
19.: Cameron JD, Lane PL, Speechley M. Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache. Acad Emerg Med. 1995 Jul;2(7):597–602. PMID: 8521205. [PubMed: 8521205]
20.: Carleton SC, Shesser RF, Pietrzak MP, et al. Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache. Ann Emerg Med. 1998 Aug;32(2):129–38. PMID: 9701293. [PubMed: 9701293]
21.: Cete Y, Dora B, Ertan C, et al. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department. Cephalalgia. 2005 Mar;25(3):199–204. PMID: 15689195. [PubMed: 15689195]
22.: Chappell AS, Bay JM, Botzum GD, et al. Zatosetron, a 5-HT3 receptor antagonist in a multicenter trial for acute migraine. Neuropharmacology. 1994 Mar–Apr;33(3–4):509–13. PMID: 7984290. [PubMed: 7984290]
23.: Chou DE, Shnayderman Yugrakh M, Winegarner D, et al. Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial. Cephalalgia. 2019 Jan;39(1):3–14. PMID: 30449151. [PMC free article: PMC6348457] [PubMed: 30449151]
24.: Connor KM, Shapiro RE, Diener HC, et al. Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology. 2009 Sep 22;73(12):970–7. PMID: 19770473. [PMC free article: PMC2754336] [PubMed: 19770473]
25.: Coppola M, Yealy DM, Leibold RA. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med. 1995 Nov;26(5):541–6. PMID: 7486359. [PubMed: 7486359]
26.: Corbo J, Esses D, Bijur PE, et al. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Ann Emerg Med. 2001 Dec;38(6):621–7. PMID: 11719739. [PubMed: 11719739]
27.: Croop R, Goadsby PJ, Stock DA, et al. Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial. Lancet. 2019 08 31;394(10200):737–45. PMID: 31311674. [PubMed: 31311674]
28.: Dahlof CGH, Hauge AW, Olesen J. Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study. Cephalalgia. 2009 Nov;29 Suppl 2:7–16. PMID: 19723121. [PubMed: 19723121]
29.: Demirkaya S, Vural O, Dora B, et al. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache. 2001 Feb;41(2):171–7. PMID: 11251702. [PubMed: 11251702]
30.: Derosier FJ, Sheftell F, Silberstein S, et al. Crossover study to evaluate the efficacy of a single fixed-dose tablet of sumatriptan and naproxen sodium (SumaRT/Nap) versus butalbital-containing combination medication (BCM) and placebo (PLA) for migraine headache. Headache. 2010 August;1):9–10. PMID: 70219789.
31.: Dexter SL, Graham AN, Johnston ES. Double-blind controlled study of paramax in the acute treatment of common and classical migraine. British Journal of Clinical Practice. 1985;39(10):388–92. PMID: 16143061. [PubMed: 3907680]
32.: Diamond S, Freitag F, Phillips SB, et al. Intranasal civamide for the acute treatment of migraine headache. Cephalalgia. 2000 Jul;20(6):597–602. PMID: 11075845. [PubMed: 11075845]
33.: Diamond S. Treatment of migraine with isometheptene, acetaminophen, and dichloralphenazone combination: a double blind, crossover trial. Headache. 1976;15(4):282–7. PMID: 6204485. [PubMed: 1107267]
34.: Diener H-C, Barbanti P, Dahlof C, et al. BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study. Cephalalgia. 2011 Apr;31(5):573–84. PMID: 21172952. [PubMed: 21172952]
35.: Diener HC. RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks. Cephalalgia. 2003 Apr;23(3):183–5. PMID: 12662184. [PubMed: 12662184]
36.: Diener H-C, Jansen J-P, Reches A, et al. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison. Eur Neurol. 2002;47(2):99–107. PMID: 11844898. [PubMed: 11844898]
37.: Dodick DW, Lipton RB, Ailani J, et al. Ubrogepant for the Treatment of Migraine. N Engl J Med. 2019 12 05;381(23):2230–41. PMID: 31800988. [PubMed: 31800988]
38.: Dogan NO, Pekdemir M, Yilmaz S, et al. Intravenous metoclopramide in the treatment of acute migraines: A randomized, placebo-controlled trial. Acta Neurol Scand. 2019 Apr;139(4):334–9. PMID: 30629285. [PubMed: 30629285]
39.: Donaldson D, Sundermann R, Jackson R, et al. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial. Am J Emerg Med. 2008 Feb;26(2):124–30. PMID: 18272089. [PubMed: 18272089]
40.: Etchison AR, Bos L, Ray M, et al. Low-dose Ketamine Does Not Improve Migraine in the Emergency Department: A Randomized Placebo-controlled Trial. West J Emerg Med. 2018 Nov;19(6):952–60. PMID: 30429927. [PMC free article: PMC6225951] [PubMed: 30429927]
41.: Farahmand S, Shafazand S, Alinia E, et al. Pain Management Using Acupuncture Method in Migraine Headache Patients; A Single Blinded Randomized Clinical Trial. Anesth. 2018 Dec;8(6):e81688. PMID: 30666295. [PMC free article: PMC6334036] [PubMed: 30666295]
42.: Farkkila M, Diener H-C, Geraud G, et al. Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study. Lancet neurol. 2012 May;11(5):405–13. PMID: 22459549. [PubMed: 22459549]
43.: Fernando T, Lumanauw DD, Youn S, et al. Buccally absorbed vs intravenous prochlorperazine for treatment of migraines headaches. Acta Neurol Scand. 2019 Jul;140(1):72–7. PMID: 30993680. [PubMed: 30993680]
44.: Ferrari MD, Farkkila M, Reuter U, et al. Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan-a randomised proof-of-concept trial. Cephalalgia. 2010 Oct;30(10):1170–8. PMID: 20855362. [PubMed: 20855362]
45.: Foroughipour M, Ghandehari K, Khazaei M, et al. Randomized clinical trial of intravenous valproate (orifil) and dexamethasone in patients with migraine disorder. Iran. 2013 Jun;38(2 Suppl):150–5. PMID: 24031104. [PMC free article: PMC3771216] [PubMed: 24031104]
46.: Freitag FG. The acute treatment of migraine with transnasal butorphanol (TNB). Headache Quarterly. 1993;4(Suppl 3):22–8. PMID: 1994-34600-001.
47.: Friedman BW, Greenwald P, Bania TC, et al. Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology. 2007 Nov 27;69(22):2038–44. PMID: 17942818. [PubMed: 17942818]
48.: Friedman AP, Di Serio FJ, Hwang DS. Symptomatic relief of migraine: multicenter comparison of Cafergot P-B, Cafergot, and placebo. Clin Ther. 1989;11(1):170–82. PMID: 2497984. [PubMed: 2497984]
49.: Friedman BW, Esses D, Solorzano C, et al. A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine. Ann Emerg Med. 2008 Oct;52(4):399–406. PMID: 18006188. [PubMed: 18006188]
50.: Friedman BW, Mulvey L, Esses D, et al. Metoclopramide for acute migraine: a dose-finding randomized clinical trial. Ann Emerg Med. 2011 May;57(5):475–82.e1. PMID: 21227540. [PMC free article: PMC3341930] [PubMed: 21227540]
51.: Friedman BW, Cabral L, Adewunmi V, et al. Diphenhydramine as Adjuvant Therapy for Acute Migraine: An Emergency Department-Based Randomized Clinical Trial. Ann Emerg Med. 2016 Jan;67(1):32–9.e3. PMID: 26320523. [PMC free article: PMC4695376] [PubMed: 26320523]
52.: Friedman BW, Mohamed S, Robbins MS, et al. A Randomized, Sham-Controlled Trial of Bilateral Greater Occipital Nerve Blocks With Bupivacaine for Acute Migraine Patients Refractory to Standard Emergency Department Treatment With Metoclopramide. Headache. 2018 Oct;58(9):1427–34. PMID: 30144034. [PubMed: 30144034]
53.: Friedman BW, Irizarry E, Solorzano C, et al. Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine. Neurology. 2017 Nov 14;89(20):2075–82. PMID: 29046364. [PMC free article: PMC5711508] [PubMed: 29046364]
54.: Fuglsang CH, Johansen T, Kaila K, et al. Treatment of acute migraine by a partial rebreathing device: A randomized controlled pilot study. Cephalalgia. 2018 09;38(10):1632–43. PMID: 30134739. [PMC free article: PMC6158684] [PubMed: 30134739]
55.: Gaffigan ME, Bruner DI, Wason C, et al. A Randomized Controlled Trial of Intravenous Haloperidol vs. Intravenous Metoclopramide for Acute Migraine Therapy in the Emergency Department. J Emerg Med. 2015 Sep;49(3):326–34. PMID: 26048068. [PubMed: 26048068]
56.: Gallagher RM. Acute treatment of migraine with dihydroergotamine nasal spray. Dihydroergotamine Working Group. Arch Neurol. 1996 Dec;53(12):1285–91. PMID: 8970458. [PubMed: 8970458]
57.: Gerhardt RT, Hermstad E, Crawford DM, et al. Postdischarge secobarbital after ED migraine treatment decreases pain and improves resolution. Am J Emerg Med. 2011 Jan;29(1):86–90. PMID: 20825791. [PubMed: 20825791]
58.: Goadsby PJ, Wietecha LA, Dennehy EB, et al. Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine. Brain. 2019 Jul 01;142(7):1894–904. PMID: 31132795. [PMC free article: PMC6620826] [PubMed: 31132795]
59.: Goldstein DJ, Wang O, Saper JR, et al. Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study. Cephalalgia. 1997 Nov;17(7):785–90. PMID: 9399010. [PubMed: 9399010]
60.: Gomez-Mancilla B, Cutler NR, Leibowitz MT, et al. Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine. Cephalalgia. 2001 Sep;21(7):727–32. PMID: 11595000. [PubMed: 11595000]
61.: Gomez-Mancilla B, Brand R, Jurgens TP, et al. Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks. Cephalalgia. 2014 Feb;34(2):103–13. PMID: 23963355. [PubMed: 23963355]
62.: Griffith JD, Mycyk MB, Kyriacou DN. Metoclopramide versus hydromorphone for the emergency department treatment of migraine headache. J Pain. 2008 Jan;9(1):88–94. PMID: 17981511. [PubMed: 17981511]
63.: Hakkarainen H, Allonen H. Ergotamine vs. metoclopramide vs. their combination in acute migraine attacks. Headache. 1982 Jan;22(1):10–2. PMID: 17152739. [PubMed: 17152739]
64.: Hewitt DJ, Martin V, Lipton RB, et al. Randomized controlled study of telcagepant plus ibuprofen or acetaminophen in migraine. Headache. 2011 Apr;51(4):533–43. PMID: 21457238. [PubMed: 21457238]
65.: Hewitt DJ, Aurora SK, Dodick DW, et al. Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine. Cephalalgia. 2011 Apr;31(6):712–22. PMID: 21383045. [PubMed: 21383045]
66.: Ho TW, Mannix LK, Fan X, et al. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology. 2007 2007/10/03;70(16):1304–12. [PubMed: 17914062]
67.: Ho TW, Ferrari MD, Dodick DW, et al. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet. 2008 Dec 20;372(9656):2115–23. PMID: 19036425. [PubMed: 19036425]
68.: Ho AP, Dahlof CG, Silberstein SD, et al. Randomized, controlled trial of telcagepant over four migraine attacks. Cephalalgia. 2010 Dec;30(12):1443–57. PMID: 20974601. [PubMed: 20974601]
69.: Ho TW, Ho AP, Chaitman BR, et al. Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease. Headache. 2012 Feb;52(2):224–35. PMID: 22221076. [PubMed: 22221076]
70.: Hoffert MJ, Scholz MJ, Kanter R. A double-blind controlled study of nifedipine as an abortive treatment in acute attacks of migraine with aura. Cephalalgia. 1992 Oct;12(5):323–4. PMID: 1423566. [PubMed: 1423566]
71.: Hoffert MJ, Couch JR, Diamond S, et al. Transnasal butorphanol in the treatment of acute migraine. Headache. 1995 Feb;35(2):65–9. PMID: 7737863. [PubMed: 7737863]
72.: Hokenek NM, Erdogan MO, Hokenek UD, et al. Treatment of migraine attacks by transcutaneous electrical nerve stimulation in emergency department: A randomize controlled trial. Am J Emerg Med. 2020 Jan 15;15:15. PMID: 31983598. [PubMed: 31983598]
73.: Honkaniemi J, Liimatainen S, Rainesalo S, et al. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study. Headache. 2006 May;46(5):781–7. PMID: 16643581. [PubMed: 16643581]
74.: Hougaard A, Hauge AW, Guo S, et al. The nitric oxide synthase inhibitor and serotonin-receptor agonist NXN-188 during the aura phase of migraine with aura: A randomized, double-blind, placebo-controlled cross-over study. Scand J Pain. 2013 Jan 01;4(1):48–52. PMID: 29913885. [PubMed: 29913885]
75.: Jones EB, Gonzalez ER, Boggs JG, et al. Safety and efficacy of rectal prochlorperazine for the treatment of migraine in the emergency department. Ann Emerg Med. 1994 Aug;24(2):237–41. PMID: 8037389. [PubMed: 8037389]
76.: Jones J, Pack S, Chun E. Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache. Am J Emerg Med. 1996 May;14(3):262–4. PMID: 8639197. [PubMed: 8639197]
77.: Jones CW, Remboski LB, Freeze B, et al. Intravenous Fluid for the Treatment of Emergency Department Patients With Migraine Headache: A Randomized Controlled Trial. Ann Emerg Med. 2019 Feb;73(2):150–6. PMID: 30665504. [PubMed: 30665504]
78.: Kangasniemi P, Kaaja R. Ketoprofen and ergotamine in acute migraine. J Intern Med. 1992 May;231(5):551–4. PMID: 1602293. [PubMed: 1602293]
79.: Kapicioglu S, Gokce E, Kapicioglu Z, et al. Treatment of migraine attacks with a long-acting somatostatin analogue (octreotide, SMS 201-995). Cephalalgia. 1997 Feb;17(1):27–30. PMID: 9051332. [PubMed: 9051332]
80.: Karimi N, Tavakoli M, Charati JY, et al. Single-dose intravenous sodium valproate (Depakine) versus dexamethasone for the treatment of acute migraine headache: a double-blind randomized clinical trial. Clin. 2017 Sep;4(3):138–45. PMID: 29026887. [PMC free article: PMC5635457] [PubMed: 29026887]
81.: Klapper JA, Stanton J. Current emergency treatment of severe migraine headaches. Headache. 1993 Nov–Dec;33(10):560–2. PMID: 8294195. [PubMed: 8294195]
82.: Korucu O, Dagar S, Corbacioglu SK, et al. The effectiveness of greater occipital nerve blockade in treating acute migraine-related headaches in emergency departments. Acta Neurol Scand. 2018 Sep;138(3):212–8. PMID: 29744871. [PubMed: 29744871]
83.: Kuca B, Silberstein SD, Wietecha L, et al. Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study. Neurology. 2018 12 11;91(24):e2222–e32. PMID: 30446595. [PMC free article: PMC6329326] [PubMed: 30446595]
84.: Lane PL, McLellan BA, Baggoley CJ. Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med. 1989 Apr;18(4):360–5. PMID: 2705667. [PubMed: 2705667]
85.: Levy MJ, Matharu MS, Bhola R, et al. Octreotide is not effective in the acute treatment of migraine. Cephalalgia. 2005 Jan;25(1):48–55. PMID: 15606570. [PubMed: 15606570]
86.: Li Y, Liang F, Yang X, et al. Acupuncture for treating acute attacks of migraine: a randomized controlled trial. Headache. 2009 Jun;49(6):805–16. PMID: 19438740. [PubMed: 19438740]
87.: Lipton RB, Baggish JS, Stewart WF, et al. Efficacy and Safety of Acetaminophen in the Treatment of Migraine. Archives of Internal Medicine. 2000 2000/12/11;160(22):3486. [PubMed: 11112243]
88.: Lipton RB, Dodick DW, Silberstein SD, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet neurol. 2010 Apr;9(4):373–80. PMID: 20206581. [PubMed: 20206581]
89.: Lipton RB, Croop R, Stock EG, et al. Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine. N Engl J Med. 2019 07 11;381(2):142–9. PMID: 31291516. [PubMed: 31291516]
90.: Lipton RB, Dodick DW, Ailani J, et al. Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial. Jama. 2019 11 19;322(19):1887–98. PMID: 31742631. [PMC free article: PMC6865323] [PubMed: 31742631]
91.: Loisy C, Beorchia S, Centonze V, et al. Effects on migraine headache of MDL 72,222, an antagonist at neuronal 5-HT receptors. Double-blind, placebo-controlled study. Cephalalgia. 1985 Jun;5(2):79–82. PMID: 3893732. [PubMed: 3893732]
92.: Maizels M, Scott B, Cohen W, et al. Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial. Jama. 1996 Jul 24–31;276(4):319–21. PMID: 8656545. [PubMed: 8656545]
93.: Maizels M, Geiger AM. Intranasal lidocaine for migraine: a randomized trial and open-label follow-up. Headache. 1999 Sep;39(8):543–51. PMID: 11279969. [PubMed: 11279969]
94.: Marcus SV. Phase 1 of integrated EMDR: An abortive treatment for migraine headaches. Journal of EMDR Practice and Research. 2008;2(1):15–25. PMID: 2008-09907-002.
95.: Marcus R, Goadsby PJ, Dodick D, et al. BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial. Cephalalgia. 2014 Feb;34(2):114–25. PMID: 23965396. [PubMed: 23965396]
96.: Mazaheri S, Poorolajal J, Hosseinzadeh A, et al. Effect of intravenous sodium valproate vs dexamethasone on acute migraine headache: a double blind randomized clinical trial. PLoS ONE. 2015;10(3):e0120229. PMID: 25793707. [PMC free article: PMC4368536] [PubMed: 25793707]
97.: McEwen JI, O’Connor HM, Dinsdale HB. Treatment of migraine with intramuscular chlorpromazine. Ann Emerg Med. 1987 Jul;16(7):758–63. PMID: 3592329. [PubMed: 3592329]
98.: Miller MA, Levsky ME, Enslow W, et al. Randomized evaluation of octreotide vs prochlorperazine for ED treatment of migraine headache. Am J Emerg Med. 2009 Feb;27(2):160–4. PMID: 19371522. [PubMed: 19371522]
99.: Million R, Finlay BR, Whittington JR. Clinical trial of flupirtine maleate in patients with migraine. Curr Med Res Opin. 1984;9(3):204–12. PMID: 6389014. [PubMed: 6389014]
100.: Mitra B, Roman C, Mercier E, et al. Propofol for migraine in the emergency department: A pilot randomised controlled trial. Emerg Med Australas. 2020 Aug;32(4):542–7. PMID: 32705801. [PubMed: 32705801]
101.: Molaie M, Olson CM, Koch J. The effect of intravenous verapamil on acute migraine headache. Headache. 1987;27(1):51–3. PMID: 17149493. [PubMed: 3549629]
102.: Niazi M, Hashempur MH, Taghizadeh M, et al. Efficacy of topical Rose (Rosa damascena Mill.) oil for migraine headache: A randomized double-blinded placebo-controlled cross-over trial. Complement Ther Med. 2017 Oct;34:35–41. PMID: 28917373. [PubMed: 28917373]
103.: Pfaffenrath V, Oestreich W, Haase W. Flunarizine (10 and 20 mg) i.v. versus placebo in the treatment of acute migraine attacks: a multi-centre double-blind study. Cephalalgia. 1990 Apr;10(2):77–81. PMID: 2193713. [PubMed: 2193713]
104.: Prior MJ, Codispoti JR, Fu M. A randomized, placebo-controlled trial of acetaminophen for treatment of migraine headache. Headache. 2010 May;50(5):819–33. PMID: 20236342. [PubMed: 20236342]
105.: Rafieian-Kopaei M, Hasanpour-Dehkordi A, Lorigooini Z, et al. Comparing the Effect of Intranasal Lidocaine 4% with Peppermint Essential Oil Drop 1.5% on Migraine Attacks: A Double-Blind Clinical Trial. Int J Prev Med. 2019;10:121. PMID: 31404204. [PMC free article: PMC6647908] [PubMed: 31404204]
106.: Rapoport A, Sheftell F, Couch J, et al. Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Headache. 1995;35(4):177–84. PMID: 25142544. [PubMed: 7775172]
107.: Reutens DC, Fatovich DM, Stewart-Wynne EG, et al. Is intravenous lidocaine clinically effective in acute migraine? Cephalalgia. 1991 Dec;11(6):245–7. PMID: 1790567. [PubMed: 1790567]
108.: Richman PB, Allegra J, Eskin B, et al. A randomized clinical trial to assess the efficacy of intramuscular droperidol for the treatment of acute migraine headache. Am J Emerg Med. 2002 Jan;20(1):39–42. PMID: 11781912. [PubMed: 11781912]
109.: Rowat BM, Merrill CF, Davis A, et al. A double-blind comparison of granisetron and placebo for the treatment of acute migraine in the emergency department. Cephalalgia. 1991 Nov;11(5):207–13. PMID: 1663423. [PubMed: 1663423]
110.: Ryan RE. Double-blind clinical evaluation of the efficacy and safety of ergostine-caffeine, ergotamine-caffeine, and placebo in migraine headache. Headache. 1970 Jan;9(4):212–20. PMID: 4904954. [PubMed: 4904954]
111.: Salazar G, Fragoso M, Vergez L, et al. Metoclopramide as an analgesic in severe migraine attacks: an open, single-blind, parallel control study. Recent Patents CNS Drug Discov. 2011 May 01;6(2):141–5. PMID: 21585330. [PubMed: 21585330]
112.: Sang CN, Ramadan NM, Wallihan RG, et al. LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine. Cephalalgia. 2004 Jul;24(7):596–602. PMID: 15196302. [PubMed: 15196302]
113.: Sasannejad P, Saeedi M, Shoeibi A, et al. Lavender essential oil in the treatment of migraine headache: a placebo-controlled clinical trial. Eur Neurol. 2012;67(5):288–91. PMID: 22517298. [PubMed: 22517298]
114.: Scherl ER, Wilson JF. Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache. 1995 May;35(5):256–9. PMID: 7775186. [PubMed: 7775186]
115.: Shahrami A, Assarzadegan F, Hatamabadi HR, et al. Comparison of therapeutic effects of magnesium sulfate vs. dexamethasone/metoclopramide on alleviating acute migraine headache. J Emerg Med. 2015 Jan;48(1):69–76. PMID: 25278139. [PubMed: 25278139]
116.: Sharma S, Prasad A, Nehru R, et al. Efficacy and tolerability of prochlorperazine buccal tablets in treatment of acute migraine. Headache. 2002 Oct;42(9):896–902. PMID: 12390617. [PubMed: 12390617]
117.: Silberstein SD, Freitag FG, Rozen TD, et al. Tramadol/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial. Headache. 2005 Nov–Dec;45(10):1317–27. PMID: 16324164. [PubMed: 16324164]
118.: Silberstein SD, Schoenen J, Gobel H, et al. Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine. Cephalalgia. 2009 Nov;29 Suppl 2:17–27. PMID: 19723122. [PubMed: 19723122]
119.: Silberstein SD, Young WB, Mendizabal JE, et al. Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial. Neurology. 2003 Jan 28;60(2):315–21. PMID: 12552051. [PubMed: 12552051]
120.: Soleimanpour H, Ghafouri RR, Taheraghdam A, et al. Effectiveness of intravenous dexamethasone versus propofol for pain relief in the migraine headache: a prospective double blind randomized clinical trial. BMC Neurol. 2012 Sep 29;12:114. PMID: 23020264. [PMC free article: PMC3522017] [PubMed: 23020264]
121.: Soyka D, Taneri Z, Oestreich W, et al. Flunarizine i.v. in the acute treatment of the migraine attack. A double-blind placebo-controlled study. Cephalalgia. 1988;8 Suppl 8:35–40. PMID: 3180201. [PubMed: 3180201]
122.: Soyka D, Taneri Z, Oestreich W, et al. Flunarizine i.v. in the acute treatment of common or classical migraine attacks-a placebo-controlled double blind trial. Headache. 1989 Jan;29(1):21–7. PMID: 2647666. [PubMed: 2647666]
123.: Stiell IG, Dufour DG, Moher D, et al. Methotrimeprazine versus meperidine and dimenhydrinate in the treatment of severe migraine: a randomized, controlled trial. Ann Emerg Med. 1991 Nov;20(11):1201–5. PMID: 1952306. [PubMed: 1952306]
124.: Swidan SZ, Lake AE, rd S. Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache. Curr Pain Headache Rep. 2005 Feb;9(1):65–70. PMID: 15625028. [PubMed: 15625028]
125.: Taheraghdam AA, Amiri H, Shojaan H, et al. Intravenous dexamethasone versus morphine in relieving of acute migraine headache. Pak. 2011 Jun 15;14(12):682–7. PMID: 22303641. [PubMed: 22303641]
126.: Tanen DA, Miller S, French T, et al. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial. Ann Emerg Med. 2003 Jun;41(6):847–53. PMID: 12764341. [PubMed: 12764341]
127.: Tassorelli C, Grazzi L, e Tommaso M, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study. Neurology. 2018 07 24;91(4):e364–e73. PMID: 29907608. [PMC free article: PMC6070381] [PubMed: 29907608]
128.: Tek DS, McClellan DS, Olshaker JS, et al. A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med. 1990 Oct;19(10):1083–7. PMID: 2221512. [PubMed: 2221512]
129.: Treves TA, Kuritzky A, Hering R, et al. Dihydroergotamine nasal spray in the treatment of acute migraine. Headache. 1998 Sep;38(8):614–7. PMID: 11398305. [PubMed: 11398305]
130.: Triner WR, Bartfield JM, Birdwell M, et al. Nitrous oxide for the treatment of acute migraine headache. Am J Emerg Med. 1999 May;17(3):252–4. PMID: 10337883. [PubMed: 10337883]
131.: Tulunay FC, Ergun H, Gulmez SE, et al. The efficacy and safety of dipyrone (Novalgin) tablets in the treatment of acute migraine attacks: a double-blind, cross-over, randomized, placebo-controlled, multi-center study. Funct Neurol. 2004 Jul–Sep;19(3):197–202. PMID: 15595715. [PubMed: 15595715]
132.: Tulunay FC, Karan O, Aydin N, et al. Dihydroergotamine nasal spray during migraine attacks. A double-blind crossover study with placebo. Cephalalgia. 1987 Jun;7(2):131–3. PMID: 3301001. [PubMed: 3301001]
133.: Voss T, Lipton RB, Dodick DW, et al. A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine. Cephalalgia. 2016 Aug;36(9):887–98. PMID: 27269043. [PubMed: 27269043]
134.: Wang L-P, Zhang X-Z, Guo J, et al. Efficacy of acupuncture for acute migraine attack: a multicenter single blinded, randomized controlled trial. Pain Med. 2012 May;13(5):623–30. PMID: 22536889. [PubMed: 22536889]
135.: Wasay M, Zaki KS, Khan SU, et al. Narcotic analgesics for acute migraine in the emergency room: are we meeting Headache Societies’ guidelines? J Headache Pain. 2006 Dec;7(6):413–5. PMID: 17149566. [PMC free article: PMC3452227] [PubMed: 17149566]
136.: Yang J, Zeng F, Feng Y, et al. A PET-CT study on the specificity of acupoints through acupuncture treatment in migraine patients. BMC Altern Med. 2012 Aug 15;12:123. PMID: 22894176. [PMC free article: PMC3480944] [PubMed: 22894176]
137.: Yarnitsky D, Volokh L, Ironi A, et al. Nonpainful remote electrical stimulation alleviates episodic migraine pain. Neurology. 2017 Mar 28;88(13):1250–5. PMID: 28251920. [PubMed: 28251920]
138.: Yarnitsky D, Dodick DW, Grosberg BM, et al. Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Headache. 2019 Sep;59(8):1240–52. PMID: 31074005. [PMC free article: PMC6767146] [PubMed: 31074005]
139.: Zargaran A, Borhani-Haghighi A, Salehi-Marzijarani M, et al. Evaluation of the effect of topical chamomile (Matricaria chamomilla L.) oleogel as pain relief in migraine without aura: a randomized, double-blind, placebo-controlled, crossover study. Neurol Sci. 2018 Aug;39(8):1345–53. PMID: 29808331. [PubMed: 29808331]
140.: Ziegler D, Ford R, Kriegler J, et al. Dihydroergotamine nasal spray for the acute treatment of migraine. Neurology. 1994 Mar;44(3 Pt 1):447–53. PMID: 8145914. [PubMed: 8145914]
141.: Ashcroft DM, Millson D. Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials. Pharmacoepidemiol Drug Saf. 2004 Feb;13(2):73–82. PMID: 14998068. [PubMed: 14998068]
142.: Bird S, Derry S, Moore AR. Zolmitriptan for acute migraine attacks in adults. Cochrane Database of Systematic Reviews. 2019(5). PMID: 00075320-100000000-07070. [PMC free article: PMC6485805] [PubMed: 24848613]
143.: Chen L-C, Ashcroft DM. Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine. Headache. 2007 Sep;47(8):1169–77. PMID: 17883521. [PubMed: 17883521]
144.: Cady R. Almotriptan reduces the incidence of migraine-associated symptoms: a pooled analysis. Headache. 2002 Jan;42 Suppl 1:26–31. PMID: 11966861. [PubMed: 11966861]
145.: Dahlof CG, Pascual J, Dodick DW, et al. Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials. Cephalalgia. 2006 Apr;26(4):400–8. PMID: 16556240. [PubMed: 16556240]
146.: Derry CJ, Derry S, Moore RA. Sumatriptan (oral route of administration) for acute migraine attacks in adults. Cochrane Database of Systematic Reviews. 2012 Feb 15(2):CD008615. PMID: 22336849. [PMC free article: PMC4167868] [PubMed: 22336849]
147.: Derry CJ, Derry S, Moore RA. Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults. The Cochrane database of systematic reviews. 2012 Feb 15;2012(2):Cd009665. doi: 10.1002/14651858.Cd009665. PMID: 22336869. [PMC free article: PMC4164380] [PubMed: 22336869] [CrossRef]
148.: Ferrari M, Loder E, McCarroll K, et al. Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials. Cephalalgia. 2001;21(2):129–36. doi: 10.1046/j.1468-2982.2001.00169.x. [PubMed: 11422095] [CrossRef]
149.: Mandema JW, Cox E, Alderman J. Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain-results of a model-based meta-analysis that accounts for encapsulation. Cephalalgia. 2005 Sep;25(9):715–25. PMID: 16109054. [PubMed: 16109054]
150.: Menshawy A, Ahmed H, Ismail A, et al. Intranasal sumatriptan for acute migraine attacks: a systematic review and meta-analysis. Neurol Sci. 2018 Jan;39(1):31–44. PMID: 28942578. [PubMed: 28942578]
151.: Poolsup N, Leelasangaluk V, Jittangtrong J, et al. Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials. J Clin Pharm Ther. 2005 Dec;30(6):521–32. PMID: 16336284. [PubMed: 16336284]
152.: Derry S, Rabbie R, Moore RA. Diclofenac with or without an antiemetic for acute migraine headaches in adults. Cochrane Database of Systematic Reviews. 2013(4). doi: 10.1002/14651858.CD008783.pub3. PMID: CD008783. [PMC free article: PMC6483674] [PubMed: 23633360] [CrossRef]
153.: Derry S, Moore RA. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. The Cochrane database of systematic reviews. 2013;2013(4):CD008040–CD. doi: 10.1002/14651858.CD008040.pub3. PMID: 23633349. [PMC free article: PMC6483792] [PubMed: 23633349] [CrossRef]
154.: Kirthi V, Derry S, Moore RA. Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database of Systematic Reviews. 2013(4). doi: 10.1002/14651858.CD008041.pub3. PMID: CD008041. [PMC free article: PMC6483629] [PubMed: 23633350] [CrossRef]
155.: Rabbie R, Derry S, Moore RA. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. The Cochrane database of systematic reviews. 2013 Apr 30;2013(4):Cd008039. doi: 10.1002/14651858.CD008039.pub3. PMID: 23633348. [PMC free article: PMC6457976] [PubMed: 23633348] [CrossRef]
156.: Taggart E, Doran S, Kokotillo A, et al. Ketorolac in the treatment of acute migraine: a systematic review. Headache. 2013 Feb;53(2):277–87. PMID: 23298250. [PubMed: 23298250]
157.: Law S, Derry S, Moore RA. Sumatriptan plus naproxen for acute migraine attacks in adults. Cochrane Database of Systematic Reviews. 2013 Oct 21(10):CD008541. PMID: 24142431. [PubMed: 24142431]
158.: Xu H, Han W, Wang J, et al. Network meta-analysis of migraine disorder treatment by NSAIDs and triptans. J Headache Pain. 2016 Dec;17(1):113. doi: 10.1186/s10194-016-0703-0. PMID: 27957624. [PMC free article: PMC5153398] [PubMed: 27957624] [CrossRef]
159.: Tepper SJ, Vasudeva R, Krege JH, et al. Evaluation of 2-Hour Post-Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult-to-Treat Migraine Attacks. Headache. 2020 Jul 07;07:07. PMID: 32634275. [PMC free article: PMC7496706] [PubMed: 32634275]

Bookshelf ID: NBK566236

Contents

< PrevNext >

PubReader
Print View
Cite this Page
Singh RBH, VanderPluym JH, Morrow AS, et al. Acute Treatments for Episodic Migraine [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Dec. (Comparative Effectiveness Review, No. 239.) Appendix M, Appendix References.
PDF version of this title (2.8M)